Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.
2.

VISTA: A μ-Thermogravimeter for Investigation of Volatile Compounds in Planetary Environments.

Palomba E, Longobardo A, Dirri F, Zampetti E, Biondi D, Saggin B, Bearzotti A, Macagnano A.

Orig Life Evol Biosph. 2016 Jun;46(2-3):273-81. doi: 10.1007/s11084-015-9473-y. Epub 2015 Nov 24.

PMID:
26603435
3.

Tolerability and efficacy of tapentadol extended release in elderly patients ≥ 75 years of age with chronic osteoarthritis knee or low back pain.

Biondi DM, Xiang J, Etropolski M, Moskovitz B.

J Opioid Manag. 2015 Sep-Oct;11(5):393-403. doi: 10.5055/jom.2015.0289.

PMID:
26535967
4.

Validation of the Hospital Anxiety and Depression Scale in Patients With Acute Low Back Pain.

Turk DC, Dworkin RH, Trudeau JJ, Benson C, Biondi DM, Katz NP, Kim M.

J Pain. 2015 Oct;16(10):1012-21. doi: 10.1016/j.jpain.2015.07.001. Epub 2015 Jul 21.

PMID:
26208762
5.

Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain.

Dworkin RH, Turk DC, Trudeau JJ, Benson C, Biondi DM, Katz NP, Kim M.

J Pain. 2015 Apr;16(4):357-66. doi: 10.1016/j.jpain.2015.01.012. Epub 2015 Jan 29.

PMID:
25640290
6.

Evaluation of blood pressure and heart rate in patients with hypertension who received tapentadol extended release for chronic pain: a post hoc, pooled data analysis.

Biondi DM, Xiang J, Etropolski M, Moskovitz B.

Clin Drug Investig. 2014 Aug;34(8):565-76. doi: 10.1007/s40261-014-0209-y.

7.

Economic burden of back and neck pain: effect of a neuropathic component.

Kleinman N, Patel AA, Benson C, Macario A, Kim M, Biondi DM.

Popul Health Manag. 2014 Aug;17(4):224-32. doi: 10.1089/pop.2013.0071. Epub 2014 Mar 31.

PMID:
24684443
8.

RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response.

Yin X, Luistro L, Zhong H, Smith M, Nevins T, Schostack K, Hilton H, Lin TA, Truitt T, Biondi D, Wang X, Packman K, Rosinski J, Berkofsky-Fessler W, Tang JP, Pant S, Geho D, Vega-Harring S, Demario M, Levitsky H, Simcox M.

Clin Cancer Res. 2013 Oct 15;19(20):5686-98. doi: 10.1158/1078-0432.CCR-13-0405. Epub 2013 Aug 23.

9.

Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.

Biondi D, Xiang J, Benson C, Etropolski M, Moskovitz B, Rauschkolb C.

Pain Physician. 2013 May-Jun;16(3):E237-46.

10.

Pigeons' choices with token stimuli in concurrent variable-interval schedules.

Mazur JE, Biondi DR.

J Exp Anal Behav. 2013 Mar;99(2):159-78. doi: 10.1002/jeab.12. Epub 2013 Jan 2.

11.

Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: a national multifaceted assessment of physicians, pharmacists, and their patients.

Salinas GD, Susalka D, Burton BS, Roepke N, Evanyo K, Biondi D, Nicholson S.

J Opioid Manag. 2012 Sep-Oct;8(5):273-84. doi: 10.5055/jom.2012.0127.

PMID:
23247904
12.

Economic study on the impact of side effects in patients taking oxycodone controlled-release for noncancer pain.

Anastassopoulos KP, Chow W, Tapia CI, Baik R, Ackerman SJ, Biondi D, Kim MS.

J Manag Care Pharm. 2012 Oct;18(8):615-26.

13.

Imputing at-work productivity loss using results of a randomized controlled trial comparing tapentadol extended release and oxycodone controlled release for osteoarthritis pain.

Lerner D, Chang H, Rogers WH, Benson C, Chow W, Kim MS, Biondi D.

J Occup Environ Med. 2012 Aug;54(8):933-8. doi: 10.1097/JOM.0b013e31825f31a1.

PMID:
22850352
15.

Effects of time between trials on rats' and pigeons' choices with probabilistic delayed reinforcers.

Mazur JE, Biondi DR.

J Exp Anal Behav. 2011 Jan;95(1):41-56. doi: 10.1901/jeab.2011.95-41.

16.

Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.

Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.

Cephalalgia. 2011 Jan;31(1):18-30. doi: 10.1177/0333102410372427. Epub 2010 May 17.

PMID:
20974598
17.

Risk factors and trends in childhood stunting in a district in Western Uganda.

Biondi D, Kipp W, Jhangri GS, Alibhai A, Rubaale T, Saunders LD.

J Trop Pediatr. 2011 Feb;57(1):24-33. doi: 10.1093/tropej/fmq043. Epub 2010 Jun 15.

PMID:
20554516
18.

Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.

Berenson F, Vasconcellos E, Pakalnis A, Mao L, Biondi DM, Armstrong RB.

Headache. 2010 May;50(5):795-807. doi: 10.1111/j.1526-4610.2010.01655.x.

PMID:
20546320
19.

Electronic medical records as a research tool: evaluating topiramate use at a headache center.

Marmura MJ, Hopkins M, Andrel J, Young WB, Biondi DM, Rupnow MF, Armstrong RB.

Headache. 2010 May;50(5):769-78. doi: 10.1111/j.1526-4610.2010.01624.x. Epub 2010 Mar 4.

PMID:
20236335
20.

Carisbamate in essential tremor: brief report of a proof of concept study.

Elble RJ, Biondi DM, Ascher S, Wiegand F, Hulihan J.

Mov Disord. 2010 Apr 15;25(5):634-8. doi: 10.1002/mds.22872.

PMID:
20201005
21.

Delay-amount tradeoffs in choices by pigeons and rats: hyperbolic versus exponential discounting.

Mazur JE, Biondi DR.

J Exp Anal Behav. 2009 Mar;91(2):197-211. doi: 10.1901/jeab.2009.91-197.

22.

Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse.

Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ.

Cephalalgia. 2009 Oct;29(10):1021-7. doi: 10.1111/j.1468-2982.2009.01859.x. Epub 2009 Apr 23. Review.

PMID:
19735529
23.

Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine.

Bigal ME, Lipton RB, Biondi DM, Xiang J, Hulihan J.

Cephalalgia. 2009 Nov;29(11):1188-96. doi: 10.1111/j.1468-2982.2009.01853.x. Epub 2009 Apr 9.

PMID:
19558539
24.

Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.

Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J; CAPSS-277 Investigator Group.

Clin Ther. 2009 Mar;31(3):542-59. doi: 10.1016/j.clinthera.2009.03.020.

PMID:
19393844
25.

Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.

Cady RK, Freitag FG, Mathew NT, Elkind AH, Mao L, Fisher AC, Biondi DM, Finlayson G, Greenberg SJ, Hulihan JF.

Headache. 2009 Mar;49(3):350-63. doi: 10.1111/j.1526-4610.2009.01340.x. Epub 2009 Feb 11.

PMID:
19220503
26.

Is migraine a neuropathic pain syndrome?

Biondi DM.

Curr Pain Headache Rep. 2006 Jun;10(3):167-78. Review.

PMID:
18778570
27.

Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.

Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G, Freitag F, Schwalen S, Ascher S, Morein J, Greenberg S, Biondi D, Hulihan J.

Headache. 2008 Jul;48(7):1087-95. doi: 10.1111/j.1526-4610.2008.01185.x. Review.

PMID:
18687081
28.

Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.

Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D; AEGIS Investigator Study Group.

Headache. 2008 Mar;48(3):341-54. doi: 10.1111/j.1526-4610.2007.01044.x.

PMID:
18302700
29.

Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.

Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P.

Headache. 2008 Feb;48(2):248-58. doi: 10.1111/j.1526-4610.2007.01019.x.

PMID:
18234046
30.

An update on migraine pathophysiology and mechanism-based pharmacotherapeutics for migraine.

Cady R, Biondi DM.

Postgrad Med. 2006 Apr;Spec No:5-13. Review.

PMID:
17960686
31.

Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.

Limmroth V, Biondi D, Pfeil J, Schwalen S.

Headache. 2007 Jan;47(1):13-21.

PMID:
17355489
32.

Nutrition rehabilitation of undernourished children utilizing Spiruline and Misola.

Simpore J, Kabore F, Zongo F, Dansou D, Bere A, Pignatelli S, Biondi DM, Ruberto G, Musumeci S.

Nutr J. 2006 Jan 23;5:3.

33.

Nutrition rehabilitation of HIV-infected and HIV-negative undernourished children utilizing spirulina.

Simpore J, Zongo F, Kabore F, Dansou D, Bere A, Nikiema JB, Pignatelli S, Biondi DM, Ruberto G, Musumeci S.

Ann Nutr Metab. 2005 Nov-Dec;49(6):373-80. Epub 2005 Oct 11.

PMID:
16219988
34.

Dihydrostilbene derivatives from Glycyrrhiza glabra leaves.

Biondi DM, Rocco C, Ruberto G.

J Nat Prod. 2005 Jul;68(7):1099-102.

PMID:
16038558
35.

Headache attributed to psychiatric disorder: a case series.

Loder E, Biondi D.

Psychosomatics. 2005 Jul-Aug;46(4):326-33.

PMID:
16000675
36.

Physical treatments for headache: a structured review.

Biondi DM.

Headache. 2005 Jun;45(6):738-46. Review.

PMID:
15953306
37.

Noninvasive treatments for headache.

Biondi DM.

Expert Rev Neurother. 2005 May;5(3):355-62. Review.

PMID:
15938668
38.

Cervicogenic headache: a review of diagnostic and treatment strategies.

Biondi DM.

J Am Osteopath Assoc. 2005 Apr;105(4 Suppl 2):16S-22S. Review.

PMID:
15928349
39.

General principles of migraine management: the changing role of prevention.

Loder E, Biondi D.

Headache. 2005 Apr;45 Suppl 1:S33-47. Review.

PMID:
15833089
40.
41.

When can successful migraine prophylaxis be discontinued?

Evans RW, Loder E, Biondi DM.

Headache. 2004 Nov-Dec;44(10):1040-2. No abstract available.

PMID:
15546270
42.

Rheology of asphalts modified with glycidylmethacrylate functionalized polymers.

Polacco G, Stastna J, Biondi D, Antonelli F, Vlachovicova Z, Zanzotto L.

J Colloid Interface Sci. 2004 Dec 15;280(2):366-73.

PMID:
15533409
43.

Off-label prescribing of drugs in specialty headache practice.

Loder EW, Biondi DM.

Headache. 2004 Jul-Aug;44(7):636-41.

PMID:
15209684
45.
46.

Use of botulinum toxins for chronic headaches: a focused review.

Loder E, Biondi D.

Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S169-76. Review.

PMID:
12569965
47.

Disease modification in migraine: a concept that has come of age?

Loder E, Biondi D.

Headache. 2003 Feb;43(2):135-43. Review. No abstract available.

PMID:
12558770
48.

Opioid resistance in chronic daily headache: a synthesis of ideas from the bench and bedside.

Biondi DM.

Curr Pain Headache Rep. 2003 Feb;7(1):67-75. Review.

PMID:
12525274
49.

Headaches and their relationship to sleep.

Biondi DM.

Dent Clin North Am. 2001 Oct;45(4):685-700.

PMID:
11699236
50.

Cervicogenic headache: diagnostic evaluation and treatment strategies.

Biondi DM.

Curr Pain Headache Rep. 2001 Aug;5(4):361-8. Review.

PMID:
11403740

Supplemental Content

Loading ...
Support Center